
Advanced Drug Delivery Reviews, Год журнала: 2023, Номер 204, С. 115143 - 115143
Опубликована: Ноя. 24, 2023
Язык: Английский
Advanced Drug Delivery Reviews, Год журнала: 2023, Номер 204, С. 115143 - 115143
Опубликована: Ноя. 24, 2023
Язык: Английский
Polymers, Год журнала: 2022, Номер 14(13), С. 2601 - 2601
Опубликована: Июнь 27, 2022
Passive targeting is the foremost mechanism by which nanocarriers and drug-bearing macromolecules deliver their payload selectively to solid tumors. An important driver of passive enhanced permeability retention (EPR) effect, cornerstone most carrier-based tumor-targeted drug delivery efforts. Despite huge number publications showcasing successes in preclinical animal models, translation clinic has been poor, with only a few nano-based drugs currently being used for treatment cancers. Several barriers factors have adduced low efficiency tumors poor clinical translation, including characteristics macromolecules, vascular physiological barriers, heterogeneity tumor blood supply affects homogenous distribution within tumors, transport penetration depth nanoparticles matrix. To address challenges associated therapeutic efficacy humans, identified that affect effect macromolecular therapeutics nanoparticle systems need be overcome. In this review, approaches facilitate improved EPR outcomes novel are discussed.
Язык: Английский
Процитировано
101Advanced Drug Delivery Reviews, Год журнала: 2022, Номер 187, С. 114394 - 114394
Опубликована: Июнь 17, 2022
Язык: Английский
Процитировано
83Journal of Controlled Release, Год журнала: 2022, Номер 346, С. 71 - 97
Опубликована: Апрель 21, 2022
Язык: Английский
Процитировано
74Nano Letters, Год журнала: 2018, Номер 18(10), С. 6164 - 6174
Опубликована: Сен. 12, 2018
Cell membrane-camouflaged nanoparticles have appeared as a promising platform to develop active tumor targeting nanomedicines. To evade the immune surveillance, we designed composite cell biomimetic nanoplatform, namely, leutusome, which is made of liposomal incorporating plasma membrane components derived from both leukocytes (murine J774A.1 cells) and cells (head neck HN12). Exogenous phospholipids were used building blocks fuse with two membranes form nanoparticles. Liposomal exogenous only or in combination one type fabricated compared. The anticancer drug paclitaxel (PTX) was make drug-encapsulating Leutusome resembling characteristic examined confirmed vitro. A xenograft mouse model head cancer profile blood clearance kinetics, biodistribution, antitumor efficacy different results demonstrated that leutusome obtained prolonged circulation most efficient accumulating at site (79.1 ± 6.6% ID per gram tumor). Similarly, composed fractions B16 melanoma (J774A.1) showed prominent accumulation within tumor, suggesting generalization approach. Furthermore, PTX-encapsulating found potently inhibit growth while not causing systemic adverse effects.
Язык: Английский
Процитировано
130Seminars in Immunology, Год журнала: 2017, Номер 34, С. 103 - 113
Опубликована: Сен. 21, 2017
Язык: Английский
Процитировано
121Advanced Drug Delivery Reviews, Год журнала: 2017, Номер 115, С. 98 - 114
Опубликована: Апрель 7, 2017
Язык: Английский
Процитировано
116Drug Delivery, Год журнала: 2020, Номер 27(1), С. 1425 - 1437
Опубликована: Янв. 1, 2020
Drug delivery systems have shown tremendous promise to improve the diagnostic and therapeutic effects of drugs due their special property. Targeting tissue damage, tumors, or with limited toxicity at site infection is goal successful pharmaceuticals. Targeted drug has become significantly important in enhancing pharmaceutical reducing side therapeutics treatment various disease conditions. Unfortunately, clinical translation these targeted system mechanisms faces many challenges. At present, only a few can achieve high targeting efficiency after intravenous injection, even though numerous surface markers approaches been developed. Thus, cell-mediated drug-delivery received considerable attention for enhanced specificity efficacy disease. This review highlights recent advances design different types cells that explored mechanisms. A better understanding cell biology orientation new generation strategies utilize endogenous are expected provide solutions specific further facilitate translation.
Язык: Английский
Процитировано
112Advanced Healthcare Materials, Год журнала: 2017, Номер 7(3)
Опубликована: Ноя. 30, 2017
Abstract Cell functionalization with recently developed various nano‐ and microcarriers for therapeutics has significantly expanded the application of cell therapy targeted drug delivery effective treatment a number diseases. The aim this progress report is to review most recent advances in cell‐based vehicles designed as biological transporter platforms different drugs. For design vehicles, pathways functionalization, such covalent noncovalent surface modifications, internalization carriers are considered greater detail together approaches visualization vivo. In addition, several animal models study cell‐assisted discussed. Finally, possible future developments applications toward transport drugs designated location no or minimal immune response toxicity addressed light new field nanomedicine.
Язык: Английский
Процитировано
101Journal of Materials Chemistry B, Год журнала: 2017, Номер 5(22), С. 3995 - 4018
Опубликована: Янв. 1, 2017
The last twenty years have witnessed great advances in biology, medicine, and materials science, leading to the development of various nanoparticle (NP)-mediated drug delivery systems. Innovation science has led generation biodegradable, biocompatible, stimuli-responsive, targeted However, currently available nanotherapeutic technologies are not efficient, which culminated failure their clinical trials. Despite huge efforts devoted nanotherapeutics, only a small amount injected material could reach desired target. One promising strategy enhance efficiency NP is hybridize multiple materials, where each component play critical role an efficient multipurpose system. This review aims comprehensively cover different techniques, advantages, drawbacks systems develop hybrid nano-vesicles for delivery. Attention finally given hybridization benefits overcoming biological barriers It believed that advent modern nano-formulations multifunctional carriers paves way future achieve more
Язык: Английский
Процитировано
100Advanced Drug Delivery Reviews, Год журнала: 2019, Номер 148, С. 146 - 180
Опубликована: Фев. 22, 2019
Язык: Английский
Процитировано
98